Which has the lower trailing P/E, OSCR or TGTX?

TGTX has the lower trailing P/E: OSCR trades at 23.10 and TGTX at 19.05. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, OSCR or TGTX?

Over the past five years, TGTX grew revenue faster — OSCR at a 64.83% CAGR versus TGTX at 219.22%.

Is OSCR or TGTX more profitable?

TGTX runs the higher net margin — OSCR at 3.60% versus TGTX at 55.22%.

How have OSCR and TGTX total returns compared?

Over the past 5 years, OSCR delivered 14.97% and TGTX delivered 10.75% annualized total return. Past performance doesn't predict future results.

Oscar Health, Inc. (OSCR) vs TG Therapeutics, Inc. (TGTX)

A side-by-side comparison of Oscar Health, Inc. and TG Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

OSCR

Oscar Health, Inc.

$8.38B

$32.34HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TGTX

TG Therapeutics, Inc.

$7.99B

$52.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — OSCR vs TGTX

growth of $100 · dividends reinvested · last 6y

OSCR -6.8% (-1.2%/yr)TGTX +19.8% (+3.1%/yr)TGTX compounded faster over this window

OSCR TGTX

OSCR vs TGTX: by the numbers

•OSCR is the larger company ($8.38B vs $7.99B market cap).
•TGTX trades at the lower trailing earnings multiple (19.05 vs 23.10 P/E), one valuation lens rather than an overall verdict.
•TGTX converts more revenue to profit (55.22% vs 3.60% net margin).
•TGTX grew revenue faster over the past five years (219.22% vs 64.83% CAGR).

Metrics side by side

Valuation

Metric	OSCR	TGTX
P/E ratio	23.10	19.05
Forward P/E	16.94	53.62
P/S ratio	0.55	9.99
P/B ratio	4.09	13.23
EV / EBITDA	7.27	60.46
FCF yield	51.70%	0.22%

Profitability

Metric	OSCR	TGTX
Gross margin	14.38%	82.36%
Operating margin	4.07%	17.05%
Net margin	3.60%	55.22%
ROE	26.84%	73.08%
ROIC	22.98%	9.94%

Growth (annualized)

Metric	OSCR	TGTX
Revenue CAGR (5Y)	64.83%	219.22%
FCF CAGR (5Y)	80.81%	N/A
Total return CAGR (5Y)	14.97%	10.75%

Frequently asked

Which has the lower trailing P/E, OSCR or TGTX?: TGTX has the lower trailing P/E: OSCR trades at 23.10 and TGTX at 19.05. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, OSCR or TGTX?: Over the past five years, TGTX grew revenue faster — OSCR at a 64.83% CAGR versus TGTX at 219.22%.
Is OSCR or TGTX more profitable?: TGTX runs the higher net margin — OSCR at 3.60% versus TGTX at 55.22%.
How have OSCR and TGTX total returns compared?: Over the past 5 years, OSCR delivered 14.97% and TGTX delivered 10.75% annualized total return. Past performance doesn't predict future results.

Go deeper

Full OSCR analysis Full TGTX analysis Interactive comparison tool

Dig into the metrics

Oscar Health P/E ratio TG Therapeutics P/E ratio Oscar Health ROE TG Therapeutics ROE Oscar Health operating margin TG Therapeutics operating margin Oscar Health revenue growth TG Therapeutics revenue growth Oscar Health free cash flow TG Therapeutics free cash flow

Oscar Health & TG Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.